BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6538004)

  • 21. [Myasthenia gravis (3). Corticosteroid therapy of myasthenia gravis].
    Matell G; Osterman PO
    Lakartidningen; 1978 Oct; 75(41):3667-9. PubMed ID: 692233
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of myasthenia gravis: long-term administration of corticosteroids with remarks on thymectomy.
    Johns TR
    Adv Neurol; 1977; 17():99-122. PubMed ID: 888743
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
    Pascuzzi RM; Coslett HB; Johns TR
    Ann Neurol; 1984 Mar; 15(3):291-8. PubMed ID: 6721451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term corticosteroid treatment of myasthenia gravis.
    Johns TR
    Ann N Y Acad Sci; 1987; 505():568-83. PubMed ID: 3479938
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors influencing outcome of prednisone dose reduction in myasthenia gravis.
    Miano MA; Bosley TM; Heiman-Patterson TD; Reed J; Sergott RC; Savino PJ; Schatz NJ
    Neurology; 1991 Jun; 41(6):919-21. PubMed ID: 2046940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety for preoperative use of steroids for transsternal thymectomy in myasthenia gravis.
    Zieliński M; Kuzdzał J; Staniec B; Harazda M; Nabiałek T; Pankowski J; Szlubowski A; Medoń J
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):407-11. PubMed ID: 15296906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatment for myasthenia gravis.
    Otto TJ; Strugalska H
    Thorax; 1987 Mar; 42(3):199-204. PubMed ID: 3616980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymectomy in the treatment of ocular myasthenia gravis.
    Roberts PF; Venuta F; Rendina E; De Giacomo T; Coloni GF; Follette DM; Richman DP; Benfield JR
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):562-8. PubMed ID: 11547310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graded response to thymectomy in children with myasthenia gravis.
    Tracy MM; McRae W; Millichap JG
    J Child Neurol; 2009 Apr; 24(4):454-9. PubMed ID: 19339286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
    Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhalation anesthesia in myasthenic patients undergoing elective thymectomy].
    Rubio Pascual P; Ibáñez Agüir V; Abades Alvarez J; Trueba JL
    Rev Esp Anestesiol Reanim; 1988; 35(6):308-10. PubMed ID: 3238125
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Postoperative intensive care after thymectomy for myasthenia gravis].
    Engler JM; Wihlm JM; Lecoube MO; Franckhauser J; Hentz JG; Warter JM; Dupeyron JP; Morand G; Witz JP
    Ann Chir; 1990; 44(8):628-31. PubMed ID: 2270897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Juvenile myasthenia gravis and thymectomy: report of ten cases.
    de Assis JL; Marchiori PE; Zambon AA; Scaff M
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(5):234-6. PubMed ID: 1340608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Corticosteroid therapy in myasthenia gravis: preliminary considerations on the long-term treatment with prednisone].
    Cornelio F; Caraceni T; Negri S
    Riv Neurobiol; 1974; 20(14):78-86. PubMed ID: 4220136
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long term administration of oral prednisone or prednisolone in treatment of myasthenia gravis. Report of five cases (author's transl)].
    Contamin F; Singer B; Mignot B; Offenstadt G; Ecoffet M
    Sem Hop; 1978 Nov 18-25; 54(41-42):1213-8. PubMed ID: 216096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone dosage suggested every 3-4 days in myasthenia gravis.
    Dobkin BH
    Neurology; 1977 Feb; 27(2):202. PubMed ID: 556838
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of alternate-day prednisone therapy on respiratory function in myasthenia gravis.
    Newball HH; Brahim SA
    Thorax; 1976 Aug; 31(4):410-3. PubMed ID: 968798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disseminated thymoma and myasthenia gravis: dramatic response to prednisone.
    Taylor R; Tandan R; Roberts J; DiCostanzo DP; Sharma K; Fries T
    Ann Neurol; 1989 Feb; 25(2):208-9. PubMed ID: 2919872
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of thymectomy in myasthenia gravis.
    Ali SM; Abbas F; Sonawalla A; Altafullah I; Sheikh H
    J Pak Med Assoc; 1992 May; 42(5):107-11. PubMed ID: 1507385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.